News

Zacks Investment Research on MSN1h

Buy, Sell or Hold Pfizer Stock? Key Tips Ahead of Q2 Earnings

Pfizer PFE will report its second-quarter 2025 earnings on Aug. 5, before market open. The Zacks Consensus Estimate for sales ...

Novo Nordisk shares hit lowest level in over 3-years

Novo Nordisk shares dropped as low as $46.90 in Thursday’s session, their lowest level since January 2022, following a profit warning.

Novo Nordisk shares extend losses, erasing nearly all gains since Wegovy launch

Shares in Novo Nordisk fell as much as 6% on Friday to their lowest since August 2021, extending recent losses to wipe out ...

Novo Nordisk shares hit 4-year low, Trump urges US drug price cuts

Shares in Wegovy maker Novo Nordisk fell around 4% on Friday to their lowest since August 2021, after U.S. President Donald ...
Zacks Investment Research on MSN17h

Novo Nordisk (NVO) Registers a Bigger Fall Than the Market: Important Facts to Note

In the latest trading session, Novo Nordisk (NVO) closed at $47.00, marking a -6.06% move from the previous day. This change lagged the S&P 500's 0.37% loss on the day. Elsewhere, the Dow saw a ...